Cardiac Valve Replacement: Current Status

312 Pages·1985·15.596 MB·English

by  Shahbudin Rahimtoola (auth.), Jack M. Matloff M.D. (eds.)

CARDIAC VALVE REPLACEMENT
CARDIAC VALVE REPLACEMENT
CURRENT STATUS
PROCEEDINGS OF THE FOURTH INTERNATIONAL SYMPOSIUM
ON THE ST. JUDE MEDICAL@ VALVE,
MARCH 11-14, 1984
JACK M. MATLOFF, EDITOR
UI
"
MARTINUS NIJHOFF PUBLISHING
A MEMBER OF THE KLUWER ACADEMIC PUBLISHERS GROUP
BOSTON DORDRECHT LANCASTER
Copyright 1985 @ by Martinus Nijhoff Publishing, Boston
Softcover reprint of the hardcover 1st edition 1985
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system,
or transmitted in any form or by any means, mechanical, photocopying, recording, or otherwise,
without written permission of the publisher, Martinus Nijhoff Publishing, 190 Old Derby Street,
Hingham, Massachusetts 02043.
Distrihutors for North America: Distrihutors for all other countries:
Kluwer Academic Publishers Kluwer Academic Publishers Group
190 Old Derby Street Distribution Centre
Hingham, MA 02043 P.O. Box 322
3300 AH Dordrecht
The Netherlands
Library of Congress Cataloging in Publication Data
International Symposium on the St. Jude Medical
Valve (4th: 1984 : Montego Bay, Jamaica)
Cardiac valve replacement.
Includes bibliographies.
1. Heart valve prosthesis-Congresses. 1. Matloff,
Jack M. II. Title. III. Title: St. Jude Medical
Valve. [DNLM: 1. Heart Valve Prosthesis-
congresses. W3 IN924NU 4th 1984c I WG 169 1608 1984c]
RD598.I54 1984 617'.412 85-5059
ISBN-13: 978-1-4612-9629-4 e-ISBN-I3: 978-1-4613-2610-4
DOl: 10.1007/978-1-4613-2610-4
CONTENTS
Registered trademarks used in this book IX
Contributing authors xi
Dedication by Jack M. Matloff xvii
Preface by Jack M. Matloff xix
Keynote address by Denton A. Cooley xxiii
I COMPLICATIONS OF CARDIAC VALVE REPLACEMENTS AND THEIR
TREATMENT
1. Following the patient with prosthetic heart valves 3
SHAHBUDIN RAHIMTOOLA
2. Thromboembolism after cardiac valve replacement 9
LAWRENCE H. COHN
3. Nonprosthetic factors producing thromboembolism in patients with cardiac valve
substitutes: their nature and the problems of assessing their role 17
R. LEIGHTON FISK
4. Anticoagulant therapy and cardiac valvular surgery: Coumadin® and other
alternatives 25
SHAHBUDIN RAHIMTOOLA
5. Reoperation after cardiac valve surgery: elective, urgent and emergent 29
JAMES R. PLUTH
Discussion 33
LAWRENCE H. COHN, MODERATOR
v
vi Contents
II CARDIAC VALVE SUBSTITUTES: CURRENT STATUS
6. Clinical experience with the caged-ball Starr-Edwards® prosthesis 37
JAMES R. PLUTH
7. Overview of experience with the Bjork-Shiley® valve 41
DONALD B. DOTY
8. Experience with standard and supra-annular Carpentier-Edwards® porcine
bioprostheses 45
w. R. ERIC JAMIESON, MICHAEL T. JANUSZ, G. FRANK O. TYERS, ALFRED N. GEREIN,
DONALD R. RICCI, LAWRENCE H. BURR, ROBERT T. MIYAGISHIMA
9. Aortic valve replacement with the Ionescu-Shiley® bovine pericardial valve: an
81-month experience 57
LORENZO GONZALEZ-LAVIN, SEONG CHI, T. CALVIN BLAIR, J. Y. JUNG, A. G. FABAZ,
BETTY LEWIS, GEORGE DAUGHTERS
Discussion 67
DIETER HORSTKOTTE, MODERATOR
III CARDIAC VALVE REPLACEMENT IN SPECIAL CIRCUMSTANCES
10. Annuloaortic ectasia: surgical repair using a composite St. Jude Medical® valve
and Dacron ® tube graft 73
DENTON A. COOLEY
11. Valve replacement in the geriatric patient using the St. Jude Medical®
prosthesis 83
DEMETRE M. NICOLOFF, WILLIAM G. LINDSAY, KIT V. AROM, WILLIAM F. NORTHRUP, III,
THOMAS E. KERSTEN
12. Tricuspid valve replacement-a comparative experience with different valve
substitutes 91
FRANCIS WELLENS, JEAN-LOUIS LECLERC, F. DEUVAERT, G. VAN NOOTEN, J. GOLDSTEIN,
G. PRIMO
13. Double valve replacement 99
RICHARD J. GRAY, LAWRENCE S. C. CZER, AURELIO CHAUX, TIMOTHY M. BATEMAN,
MICHELE DEROBERTIS, JACK M. MATLOFF
14. Cardiac valve replacement in the presence of coronary atherosclerosis 111
JACK M. MATLOFF AND LAWRENCE S. C. CZER
Discussion 123
DONALD B. DOTY AND EUGENE M. BAUDET, MODERATORS
IV CARDIAC VALVE REPLACEMENT IN PEDIATRIC PRACTICE:
EXPERIENCE WITH THE ST. JUDE MEDICAL® VALVE
15. St. Jude Medical® valve replacement in infants and children 129
A. MICHAEL BORKON, BRUCE A. REITZ, JAMES S. DONAHOO, TIMOTHY J. GARDNER
16. Pediatric use of the St. Jude Medical® prosthesis 137
ROBERT M. SADE, FRED A. CRAWFORD, JR., HARVEY I. PASS, JOHN M. KRATZ
17. Mitral valve replacement in a child using the St. Jude Medical® valve 141
JOHN W. MACK
vii
18. Thromboembolism in children with St. Jude Medical® valves maintained on
aspirin and Persantine® 145
STUART L. BOE, KATHLEEN W. MCNICHOLAS, HENRY F. OLIVER,
FAUSTINO N. NIGUIDULA, GEORGE J. MAGOVERN, GERALD M. LEMOLE
Discussion 155
EUGENE M. BAUDET AND DONALD B. DOTY, MODERATORS
V INTERMEDIATE FOLLOW-UP OF PATIENTS WITH ST. JUDE MEDICAL®
PROSTHESES: 52 TO 72 MONTHS
19. A 52-month experience with the St. Jude Medical® cardiac prosthesis at the
Medical University of South Carolina 163
FRED A. CRAWFORD, JR., JOHN M. KRATZ, ROBERT M. SADE, MARTHA P. STROUD,
DAVID M. BARTLES
20. A 57-month experience with the St. Jude Medical® cardiac prosthesis at
Hahnemann University Hospital 167
ELDRED D. MUNDTH
21. Incidence of complication with the St. Jude Medical® prosthesis: a 58-month
study at Hamot Medical Center 173
GEORGE J. D'ANGELO, G. F. KISH, P. G. SARDESAI, W. S. TAN
22. Mitral valve replacement with St. Jude Medical® prostheses: a 60-month study of
350 cases at Centre Hospitalier Universitaire 179
HENRI DUPON, J. L. MICHAUD, D. DUVEAU, PH. DESPINS, M. TRAIN
23. A 60-month experience with the St. Jude Medical® prosthesis at Cedars-Sinai
Medical Center 189
RICHARD J. GRAY, AURELIO CHAUX, LAWRENCE S. C. CZER, MICHELE DEROBERTIS,
JACK M. MATLOFF
24. A 60-month experience with the St. Jude Medical® prosthesis at University
Hospital, Brugmann 195
JEAN-LOUIS LECLERC, FRANCIS WELLENS, FRANK E. DEUVAERT, MARTINE ANTOINE,
JACQUES DEPAEPE, GEORGES PRIMO
25. A 72-month clinical experience with the St. Jude Medical® cardiac valve
prosthesis at Newark Beth Israel Medical Center 201
ISAAC GIELCHINSKY, MARK S. HOCHBERG, S. MANSOOR HUSSAIN, VICTOR PARSONNET,
DANIEL FISCH, JOHN C. NORMAN
26. A 72-month experience with the St. Jude Medical® cardiac valve prosthesis at the
Minneapolis Heart Institute and United Hospitals, St. Paul, Minnesota 205
WILLIAM G. LINDSAY, DEMETRE NICOLOFF, KIT V. AROM, WILLIAM F. NORTHRUP III,
THOMAS E. KERSTEN
27. A 72-month clinical experience with the St. Jude Medical® prosthesis at Tucson
Medical Center 209
CHRISTOPHER T. MALONEY
Discussion 215
SHAHBUDIN RAHIMTOOLA, MODERATOR
viii Contents
VI CLINICAL EXPERIENCE WITH CURRENT CARDIAC VALVE
SUBSTITUTES: COMPARATIVE OBSERVATIONS
28. Late complications in patients with Bjork-Shiley® and St. Jude Medical®
prostheses 225
DIETER HORSTKOTTE
29. Experience with the St. Jude Medical® valve and the Ionescu-Shiley® bovine
pericardial valve at the Texas Heart Institute 233
J. MICHAEL DUNCAN, DENTON A. COOLEY, GEORGE J. REUL, DAVID A. OTT,
JAMES J. LIVESAY, O. H. FRAZIER, WILLIAM E. WALKER, PHILLIP R. ADAMS
30. Comparative assessment of single Bjork-Shiley®, Hancock® and St. Jude Medical®
valves at 43 months after operation 247
LESTER R. SAUVAGE, MARY A. O'BRIEN
Discussion 261
DEMETRE M. NICOLOFF, MODERATOR
VII CLINICAL FORUM
31. Noninvasive assessment of prosthetic heart valve function by continuous-wave
doppler ultrasound 269
ANDREAS HOFFMAN, PETER STULZ, ERICH GRADEL, DIETER BURCKHARDT
32. Potential for immobilization of the valve occluder in various valve
prostheses 281
OSCAR BAEZA
33. Escape of a leaflet from a St. Jude Medical® prosthesis in the mitral
position 285
E. HJELMS, M.D.
34. Prophylaxis against thromboembolism using aspirin and dipyridamole in patients
with the St. Jude Medical® aortic prosthesis 291
JOSEPH LOCICERO, III
Discussion 293
RICHARD J. GRAY, MODERATOR
VIII CLOSING OBSERVATIONS
35. Summary and concluding remarks 301
SHAHBUDIN RAHIMTOOLA
36. Summary and concluding observations 305
JACK M. MATLOFF
REGISTERED TRADEMARKS USED IN THIS BOOK
BJORK-SHILEY®-Shiley Corporation
CARPENTIER-EDWA RDS®-American Edwards Laboratories
COUMADIN®-The DuPont Corporation
DACRON®-The DuPont Corporation
DELRIN®-The DuPont Corporation
HANCOCK®-Vascor, Inc.
IONESCU-SHILEY® -Shiley Corporation
KEFLIN®-Eli Lilly and Company
LILLEHEI-KASTER ®-Medical Incorporated
MEADOX-COOLEY®-Meadox Medicals, Inc.
MEDTRONIC HALLTM-Blood Systems, Inc.
OMNISCIENCE®-Medical Incorporated
PERSANTINE®-Boehringer Ingelheim
SILASTIC®-Dow Coming
ST. JUDE MEDICAL®-St. Jude Medical, Inc.
STARR-EDWA RDS®-American Edwards Laboratories
STELLITE®-Cabot Corporation
SWAN-GANZ®-Edwards Laboratories
TEFLON®-DuPont Corporation
ix
CONTRIBUTING AUTHORS
Oscar Baeza, M.D.
Passaic General Hospital
Passaic, NJ 07055
Address for correspondence:
350 Boulevard
Passaic, NJ 07055
Eugene M. Baudet
Dept. of Cardiovascular Surgery
Hopital Cardiologique
Av enue de Magellan
33604 Bordeaux
France
Stuart L. Boe, M.D.
Suite 609
3661 South Miami Avenue
Miami, FL 33133
A. Michael Borkon, M.D.
Division of Cardiac Surgery
The Johns Hopkins Hospital
600 North Walfe Street
Baltimore, MD 21205
xi
xii Contributing authors
Lawrence H. Cohn, M.D.
Brigham & Women's Hospital
75 Francis Street
Boston, MA 02115
Denton A. Cooley, M.D.
P.O. Box 20345
Texas Heart Institute of
St. Luke's Episcopal and
Texas Children's Hospitals
Houston, Texas 77225
Fred A. Crawford, Jr., M.D.
The Medical University of
South Carolina
171 Ashley Avenue
Charleston, SC 29425
George J. D'Angelo, M.D.
Hamot Medical Center
Erie, PA
Address for correspondence:
104 East Second Street
Erie, P A 16507
Donald B. Doty, M.D.
LDS Hospital
Primary Children's Medical Center
Salt Lake City, UT
Address for correspondence:
324 - 10th Av enue
Salt Lake City, UT 84103
J.
Michael Duncan, M.D.
Texas Heart Institute
P.O. Box 20345
Houston, TX 77225
Prof. Henri Dupon, M.D.
35, rue Paul Bert
44035 Nantes
France